Abstract
Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Current Organic Chemistry
Title: Plant Natural Products in Anticancer Drug Discovery
Volume: 14 Issue: 16
Author(s): Paul G. Grothaus, Gordon M. Cragg and David J. Newman
Affiliation:
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Abstract: Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Export Options
About this article
Cite this article as:
G. Grothaus Paul, M. Cragg Gordon and J. Newman David, Plant Natural Products in Anticancer Drug Discovery, Current Organic Chemistry 2010; 14 (16) . https://dx.doi.org/10.2174/138527210792927708
DOI https://dx.doi.org/10.2174/138527210792927708 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of the Tissue Factor Coagulation Pathway
Current Vascular Pharmacology CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Insights into Cellular Uptake of Nanoparticles
Current Drug Delivery Synthesis of Bacteriochlorins and Their Potential Utility in Photodynamic Therapy (PDT)
Current Organic Chemistry Patented Biomarkers of Peripheral Blood for the Early Detection of Cancer
Recent Patents on Biomarkers Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology The Imaging of Apoptosis with the Radiolabelled Annexin A5: A New Tool in Translational Research
Current Clinical Pharmacology Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice
Current Gene Therapy Different Gene Therapy Strategies: A Overview for Prostate Cancer
Current Gene Therapy Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
Current Cancer Drug Targets Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Current Medicinal Chemistry Editorial [Hot Topic Ion Fluxes and Cancer (Guest Editors: Luca Munaron and Annarosa Arcangeli)]
Recent Patents on Anti-Cancer Drug Discovery Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines
Letters in Drug Design & Discovery Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies
Current Molecular Medicine A Survey of Prostate Segmentation Techniques in Different Imaging Modalities
Current Medical Imaging